Intercalating Agents

DBCAT000657Pharmacologic class

Agents that are capable of inserting themselves between the successive bases in DNA, thus kinking, uncoiling or otherwise deforming it and therefore preventing its proper functioning. They are used in the study of DNA. A DrugBank category of 9 drugs. 1 of them is approved.

Also known as: Agents, Intercalating · Compounds, Intercalative · Intercalating Ligands · Intercalative Compounds · Intercalators
Drugs: 1,10-Phenanthroline
Acriflavine
Ametantrone
Amonafide
Amsacrine
Mitonafide
Nogalamycin
Propidium
Pyrazoloacridine

What you can answer from here — as of October 27, 2022

9DrugsEach linked to its full drug card

Listed above

12Drug targetsEvery drug–target pair in the class, with bond type

30Marketed productsAcross the regions we cover, with dosage forms and routes

6Routes of administrationHow the drugs in this class are given

Which targets do Intercalating Agents share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account